Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Enliven Therapeutics (ELVN) Q4 2021 Earnings
ELVN
15
Mar
Expected
Q1 2021
Q2 2021
Q3 2021
Q4 2021
-2.96
-2.22
-1.49
-0.75
Details
Expected EPS
-0.7511
Actual EPS
-2.12
Surprise EPS
-1.37
Surprise Percent
+182.25%
Description
Enliven Therapeutics (ELVN) has reported earnings of -2.12 per share for Q4 2021.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login